Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Generac Holdings (GNRC) Catches Eye: Stock Jumps 5.6%
Generac Holdings Inc. (GNRC - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $54.13 to $56.11 in the past one month time frame.
The company has seen seven positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Generac Holdings. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Generac Holdings currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Generac Holdlings Inc. Price
Generac Holdlings Inc. Price | Generac Holdlings Inc. Quote
Another stock worth considering in the Computer and Technology sector is Apple Inc. (AAPL - Free Report) which carries a Zacks Rank #1.You can see the complete list of today’s Zacks #1 Rank stocks here.
Is GNRC going up? Or down? Predict to see what others think: Up or Down
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>